日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Acellular Human Amniotic Fluid-Derived Extracellular Vesicles as Novel Anti-Inflammatory Therapeutics against SARS-CoV-2 Infection

无细胞人羊水来源的细胞外囊泡作为新型抗炎疗法对抗SARS-CoV-2感染

Debarati Chanda ,Tania Del Rivero ,Roshan Ghimire ,Sunil More ,Maria Ines Mitrani ,Michael A Bellio ,Rudragouda Channappanavar

SARS-CoV-2 Mac1 is required for IFN antagonism and efficient virus replication in mice

SARS-CoV-2 Mac1 是小鼠中 IFN 拮抗和病毒有效复制所必需的

Yousef M Alhammad, Srivatsan Parthasarathy, Roshan Ghimire, Joseph J O'Connor, Catherine M Kerr, Jessica J Pfannenstiel, Debarati Chanda, Caden A Miller, Robert L Unckless, Sonia Zuniga, Luis Enjuanes, Sunil More, Rudragouda Channappanavar, Anthony R Fehr

SARS-CoV-2 Mac1 is required for IFN antagonism and efficient virus replication in cell culture and in mice

SARS-CoV-2 Mac1 是细胞培养和小鼠中 IFN 拮抗和病毒有效复制所必需的

Yousef M Alhammad #, Srivatsan Parthasarathy #, Roshan Ghimire #, Catherine M Kerr, Joseph J O'Connor, Jessica J Pfannenstiel, Debarati Chanda, Caden A Miller, Nathalie Baumlin, Matthias Salathe, Robert L Unckless, Sonia Zuñiga, Luis Enjuanes, Sunil More, Rudragouda Channappanavar, Anthony R Fehr